Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-SYNGAP1 Antibody Picoband® Fluoro594 Conjugated

Product Specifications

Background

Synaptic Ras GTPase-activating protein 1, also known as synaptic Ras-GAP 1 or SYNGAP1, is a protein that in humans is encoded by the SYNGAP1 gene. This gene encodes a Ras GTPase activating protein that is a member of the N-methyl-D-aspartate receptor complex. The N-terminal domain of the protein contains a Ras-GAP domain, a pleckstrin homology domain, and a C2 domain that may be involved in binding of calcium and phospholipids. The C-terminal domain consists of a ten histidine repeat region, serine and tyrosine phosphorylation sites, and a T/SXV motif required for postsynaptic scaffold protein interaction. The encoded protein negatively regulates Ras, Rap and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking to the postsynaptic membrane to regulate synaptic plasticity and neuronal homeostasis. Allelic variants of this gene are associated with intellectual disability and autism spectrum disorder. Alternative splicing results in multiple transcript variants.

Gene Name

SYNGAP1

Gene ID

8831

UniProt

Q96PV0

Host

Rabbit

Reactivity

Human, Mouse, Rat

Immunogen

E.coli-derived human SYNGAP1 recombinant protein (Position: R3-R1175) . Human SYNGAP1 shares 99% and 99.1% amino acid (aa) sequence identity with mouse and rat SYNGAP1, respectively.

Clonality

Polyclonal

Applications

Flow Cytometry

Purification

Immunogen affinity purified.

Form

Liquid

References & Citations

1. Berryer, M. H., Hamdan, F. F., Klitten, L. L., Moller, R. S., Carmant, L., Schwartzentruber, J., Patry, L., Dobrzeniecka, S., Rochefort, D., Neugnot-Cerioli, M., Lacaille, J.-C., Niu, Z., and 15 others. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum. Mutat. 34: 385-394, 2013. 2. Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., Malone, S., Wallace, G., and 22 others. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nature Genet. 45: 825-830, 2013. 3. Chen, H.-J., Rojas-Soto, M., Oguni, A., Kennedy, M. B. A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron 20: 895-904, 1998. Note: Erratum: Neuron 33: 151 only, 2002.

Storage Conditions

At -20 ̊C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

Applications Notes

6

Isotype

IgG

Contents

Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4, 0.02% NaN3.

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Phenol Red Sucrose Broth
DM 1274-01 100 g

Phenol Red Sucrose Broth

Ask
View Details
Phenol Red Sucrose Broth
DM 1274-02 500 g

Phenol Red Sucrose Broth

Ask
View Details
pCMV-SPORT6-RPSA Plasmid
PVT32233 2 µg

pCMV-SPORT6-RPSA Plasmid

Ask
View Details
KDM6B Blocking Peptide (Center)
MBS9229781-01 0.5 mg

KDM6B Blocking Peptide (Center)

Ask
View Details
KDM6B Blocking Peptide (Center)
MBS9229781-02 5x 0.5 mg

KDM6B Blocking Peptide (Center)

Ask
View Details
KV9.2 discontinued
390991 200 µL

KV9.2 discontinued

Ask
View Details